1. Tamura, Ryota. 2021. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis. In International journal of molecular sciences, 22, . doi:10.3390/ijms22115850. https://pubmed.ncbi.nlm.nih.gov/34072574/
2. Ma, Mengyin, Ge, Yu, Zhang, Tao. 2021. NF2 Gene Participates in Regulation of the Cell Cycle of Meningiomas by Restoring Spindle Assembly Checkpoint Function and Inhibiting the Binding of Cdc20 Protein to Anaphase Promoting Complex/Cyclosome. In World neurosurgery, 158, e245-e255. doi:10.1016/j.wneu.2021.10.163. https://pubmed.ncbi.nlm.nih.gov/34728400/
3. Lekanne Deprez, R H, Bianchi, A B, Groen, N A, Avezaat, C J, Kley, N. . Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. In American journal of human genetics, 54, 1022-9. doi:. https://pubmed.ncbi.nlm.nih.gov/7911002/
4. Stemmer-Rachamimov, A O, Horgan, M A, Taratuto, A L, Frosch, M P, Louis, D N. . Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene. In Journal of neuropathology and experimental neurology, 56, 485-9. doi:. https://pubmed.ncbi.nlm.nih.gov/9143261/
5. Kley, N, Seizinger, B R. . The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome? In Cancer surveys, 25, 207-18. doi:. https://pubmed.ncbi.nlm.nih.gov/8718520/